Professional
Added to YB: 2024-09-02
Pitch date: 2024-06-30
CORT [bullish]
Corcept Therapeutics Incorporated
+168.7%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Market Cap
$7.9B
Pitch Price
$32.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
106.86
P/E
86.48
EV/Sales
10.02
Sector
Pharmaceuticals
Category
growth
Show full summary:
abrdn U.S. Small Cap Equity Fund New Position: Corcept Therapeutics Incorporated
CORT: Commercial-stage biopharma co specializing in Cushing's syndrome and cortisol-related diseases. Initiated position. Bull case: next-gen drug could increase market penetration.
Read full article (1 min)